30 results on '"Shrestha, Hira"'
Search Results
2. Dryopteris cochleata (Buch.-Ham. ex D. Don) C. Chr. Dryopteris filix-mas (L.) Schott Dryopteridaceae
3. Neurobehavioral outcomes of infants exposed to buprenorphine-naloxone compared with naltrexone during pregnancy
4. Neonatal sleep development and early learning in infants with prenatal opioid exposure
5. Equisetum diffusum D. Don Equisetum ramosissimum Desf. Equisetaceae
6. Dryopteris cochleata (Buch.-Ham. ex D. Don) C. Chr. Dryopteris filix-mas (L.) Schott Dryopteridaceae
7. Dryopteris cochleata (Buch.-Ham. ex D. Don) C. Chr. Dryopteris filix-mas (L.) Schott Dryopteridaceae
8. Equisetum diffusum D. Don Equisetum ramosissimum Desf. Equisetaceae
9. Three Year Pre-analytical and Intra-individual Stability of Plasma Nutrient Biomarkers in Older Adults at Risk for Dementia: Effects of Sex, apoE Genotype and Cognition
10. Hair Cortisol Concentrations in Opioid-Exposed versus Nonexposed Mother–Infant Dyads.
11. Quality improvement initiative to improve inpatient outcomes for Neonatal Abstinence Syndrome
12. Implementation of a pilot program of Reach Out and Read® in the neonatal intensive care unit: a quality improvement initiative
13. P-099 Phase II trial of daratumumab, bortezomib, lenalidomide and dexamethasone in high-risk smoldering multiple myeloma
14. Effect of Neonatal Abstinence Syndrome Treatment Status and Maternal Depressive Symptomatology on Maternal Reports of Infant Behaviors
15. Medication for Opioid Use Disorder During Pregnancy — Maternal and Infant Network to Understand Outcomes Associated with Use of Medication for Opioid Use Disorder During Pregnancy (MAT-LINK), 2014–2021
16. Implementation of a pilot program of Reach Out and Read® in the neonatal intensive care unit: a quality improvement initiative
17. B-PRISM (Precision Intervention Smoldering Myeloma): A phase II trial of combination of daratumumab, bortezomib, lenalidomide, and dexamethasone in high-risk smoldering multiple myeloma.
18. Association of maternal and infant variants in PNOC and COMT genes with neonatal abstinence syndrome severity
19. Chapter Ten - Neonatal sleep development and early learning in infants with prenatal opioid exposure
20. Naltrexone Treatment for Pregnant Women With Opioid Use Disorder Compared With Matched Buprenorphine Control Subjects
21. Placental OPRM1 DNA methylation and associations with neonatal opioid withdrawal syndrome, a pilot study
22. Pilot Study Comparing Adverse Cardiorespiratory Events among Pharmacologically and Nonpharmacologically Treated Infants Undergoing Monitoring for Neonatal Abstinence Syndrome
23. Standard Fixed-Schedule Methadone Taper Versus Symptom-Triggered Methadone Approach for Treatment of Neonatal Opioid Withdrawal Syndrome
24. Maternal hair cortisol levels as a novel predictor of neonatal abstinence syndrome severity: A pilot feasibility study
25. Impact of psychiatric medication co-exposure on Neonatal Abstinence Syndrome severity
26. Examination of Hospital, Maternal, and Infant Characteristics Associated with Breastfeeding Initiation and Continuation Among Opioid-Exposed Mother-Infant Dyads
27. Integrating Human Papilloma Virus (HPV) Vaccination Promotion and Cervical Cancer Screening in a Diverse Inner City Primary Care Settings
28. Maternal hair cortisol levels as a novel predictor of neonatal abstinence syndrome severity: A pilot feasibility study.
29. Association of maternal and infant variants inPNOCandCOMTgenes with neonatal abstinence syndrome severity
30. Patterns of Medication for Opioid Use Disorder during Pregnancy, 7 Clinical Sites, MATernaL and Infant clinical NetworK (MAT-LINK), 2014–2021
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.